Glomerulonephritis-Induced Changes in Urinary and Kidney MicroRNA Profiles in Rats

Mira Pavkovic1, Björn Riefke2, Anna-Lena Frisk2

  • 1*Investigational Toxicology, GDD-GED-Toxicology, Bayer Pharma AG, 42096 Wuppertal, Germany, Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Sciences, Harvard Medical School, 02115 Boston, Massachusetts, Pathology, GDD-GED-Toxicology, Bayer Pharma AG, 13353 Berlin, Germany and Indication Expansion, GDD-GTRG-Cross Indication Platform, Bayer Pharma AG, 13353 Berlin, Germany *Investigational Toxicology, GDD-GED-Toxicology, Bayer Pharma AG, 42096 Wuppertal, Germany, Laboratory of Systems Pharmacology, Harvard Program in Therapeutic Sciences, Harvard Medical School, 02115 Boston, Massachusetts, Pathology, GDD-GED-Toxicology, Bayer Pharma AG, 13353 Berlin, Germany and Indication Expansion, GDD-GTRG-Cross Indication Platform, Bayer Pharma AG, 13353 Berlin, Germany.

Insights

Urinary microRNAs (miRNAs) show promise as specific biomarkers for kidney injury, differentiating between glomerulonephritis and tubular damage. These findings suggest miRNAs play a role in kidney disease pathology.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Nephrology

Background:

  • MicroRNAs (miRNAs) are key regulators of gene expression.
  • Their stability in biofluids suggests potential as biomarkers for tissue injury.
  • Urinary miRNAs are being explored for detecting site-specific renal damage.

Purpose of the Study:

  • To investigate urinary miRNAs as biomarkers for anti-glomerular basement membrane glomerulonephritis (GN) in rats.
  • To compare GN-induced urinary miRNA profiles with protein biomarkers and cisplatin-induced tubular injury.
  • To explore the role of miRNAs in kidney injury pathology.

Main Methods:

  • Induction of GN in rats using nephrotoxic serum (NTS).
  • Analysis of urinary miRNAs and protein biomarkers (creatinine, BUN).
  • Comparison with previous cisplatin (Cp) treatment data for proximal tubular injury.
  • In situ hybridization for miRNA localization and miRNA-mRNA expression analysis in kidney tissue.

Main Results:

  • NTS administration led to GN and tubular damage.
  • 74 urinary miRNAs were elevated post-NTS, with 5 specific to GN.
  • miR-10b and miR-100 localized to distal nephron segments, indicating specific tubular injury.
  • miRNA-mRNA interactions linked to fibrotic and TGF-β signaling pathways were identified.

Conclusions:

  • Urinary miRNAs can serve as specific biomarkers for kidney injury, distinguishing GN.
  • Specific miRNAs like miR-10b and miR-100 may indicate distal nephron damage.
  • miRNAs are implicated in the pathological processes of GN.

Related Concept Videos